ROBERT R. RECKER, M.D., F.A.C.P.; PAUL D. SAVILLE, M.D., F.A.C.P.; ROBERT P. HEANEY, M.D., F.A.C.P.
Sixty postmenopausal women were placed in three groups—control, sex hormone-treated, and CaCO3-treated—and followed for 2 years. Skeletal mass decreased by 1.18%/year in the control group, 0.15%/year in the hormone group, and 0.22%/year in the CaCO3 group by radiogrammetry; and 2.88%/year in the control group, 0.73%/year in the hormone group, and 1.83%/year in the CaCO3 group by photon absorptiometry. The treatment groups differed significantly from the control group except for photon absorptiometry in the CaCO3 group. Bone accretion and resorption decreased in the treatment groups as measured by calcium tracer kinetics, resorption more so than accretion. We conclude that  these techniques are sufficiently sensitive to detect age-related bone loss;  postmenopausal sex-hormone replacement measurably decreases age-related bone loss by suppressing bone turnover, resorption more than accretion; and  calcium supplements produce the same effect but at the dose we used were slightly less effective.
Learn more about subscription options.
Register Now for a free account.
RECKER RR, SAVILLE PD, HEANEY RP. Effect of Estrogens and Calcium Carbonate on Bone Loss in Postmenopausal Women. Ann Intern Med. 1977;87:649–655. doi: 10.7326/0003-4819-87-6-649
Download citation file:
Published: Ann Intern Med. 1977;87(6):649-655.
Endocrine and Metabolism, Metabolic Bone Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only